Initial Development and Characterization of PLGA Nanospheres Containing Ropivacaine

Por Moraes, Carolina Morales, de Matos, Angélica Prado, de Lima, Renata, Rosa, André Henrique, de Paula, Eneida, Fraceto, Leonardo Fernandes
Publicado em 2008

Improving the outcome of patients with castration-resistant prostate cancer through rational drug development

Por Attard, G, Sarker, D, Reid, A, Molife, R, Parker, C, de Bono, J S
Publicado em 2006

Planejamento, síntese e avaliação farmacológica de novos candidatos a agentes tuberculostáticos contendo o núcleo quinolínico /

Por Bispo, Marcelle de Lima Ferreira, Souza, Marcus Vinicius Nora de, Kaiser, Carlos Roland, Universidade Federal do Rio de Janeiro.
Publicado em 2012

Golimumab: A Novel Anti-Tumor Necrosis Factor

Por Rossini, Maurizio, De Vita, Salvatore, Ferri, Clodoveo, Govoni, Marcello, Paolazzi, Giuseppe, Salvarani, Carlo, Adami, Silvano
Publicado em 2013

Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates

Por Valitalo, Pyry A. J., van den Anker, John N., Allegaert, Karel, de Cock, Roosmarijn F. W., de Hoog, Matthijs, Simons, Sinno H. P., Mouton, Johan W., Knibbe, Catherijne A. J.
Publicado no J Antimicrob Chemother (2015)

Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity

Por Prendergast, Jillian M., Galvao da Silva, Ana Paula, Eavarone, David A., Ghaderi, Darius, Zhang, Mai, Brady, Dane, Wicks, Joan, DeSander, Julie, Behrens, Jeff, Rueda, Bo R.
Publicado no MAbs (2017)

Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization

Por Wang, Wei-Peng, Ho, Pui Yan, Chen, Qiu-Xia, Addepalli, Balasubrahmanyam, Limbach, Patrick A., Li, Mei-Mei, Wu, Wen-Juan, Jilek, Joseph L., Qiu, Jing-Xin, Zhang, Hong-Jian, Li, Tianhong, Wun, Theodore, White, Ralph DeVere, Lam, Kit S., Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2015)

Lacrimal Diversion Devices (Sinopsys Lacrimal Stent): Sharing our Experience with Patients with Chronic Rhinosinusitis without Polyposis

Por Peter Baptista, Octavio Garaycochea, Carlos Prieto-Matos, Marta Alvarez de Linera Alperi, Juan Alcalde
Publicado em 2019-05-01

Identificação de potenciais alvos moleculares e novas ferramentas terapêuticas para a leucemia linfoblástica aguda de precursores B /

Por Thiago, Leandro de Souza, Borojevic, Radovan, Universidade Federal do Rio de Janeiro.
Publicado em 2008

Reduction of Diphenyl Diselenide and Analogs by Mammalian Thioredoxin Reductase Is Independent of Their Gluthathione Peroxidase-Like Activity: A Possible Novel Pathway for Their Antioxidant Activity

Por de Freitas, Andressa Sausen, Prestes, Alessandro de Souza, Wagner, Caroline, Sudati, Jéssie Haigert, Alves, Diego, Porciúncula, Lisiane Oliveira, Kade, Ige Joseph, Rocha, João Batista Teixeira
Publicado no Molecules (2010)

A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target

Por Ibhazehiebo, Kingsley, Gavrilovici, Cezar, de la Hoz, Cristiane L, Ma, Shun-Chieh, Rehak, Renata, Kaushik, Gaurav, Meza Santoscoy, Paola L, Scott, Lucas, Nath, Nandan, Kim, Do-Young, Rho, Jong M, Kurrasch, Deborah M
Publicado no Brain (2018)

Biomarkers for the effects of antipsychotic drugs in healthy volunteers

Por de Visser, S J, van der Post, J, Pieters, M S M, Cohen, A F, van Gerven, J M A
Publicado em 2001

Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells

Por Chatterjee, Sushmita, Thaker, Nirmal, De, Abhijit
Publicado no Breast Cancer (Dove Med Press) (2015)

Assessment of the potential anticancer activity of novel lonidamine analogues /

Por Pereyra, Carolina Escardó, Silva Júnior, Floriano Paes, Dantas, Rafael Ferreira, Universidade Federal do Rio de Janeiro.
Publicado em 2018

ANGI-07. 5ALA FLUORESCENCE BASED SORTING IDENTIFIES SERPINE1 AS A NOVEL THERAPEUTIC TARGET ON INVASIVE GBM CELLS

Por Rowlinson, Jonathan, Estevez Cebrero, Maria de los Angeles, Lourdusamy, Anbarasu, Rahman, Ruman, Smith, Stuart
Publicado no Neuro Oncol (2018)

Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma

Por de la Puente, Pilar, Azab, Feda, Muz, Barbara, Luderer, Micah, Arbiser, Jack, Azab, Abdel Kareem
Publicado no Leuk Lymphoma (2015)

Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses

Por Radoshitzky, Sheli R., Kuhn, Jens H., de Kok-Mercado, Fabian, Jahrling, Peter B., Bavari, Sina
Publicado em 2012

Nanofabricated particles for engineered drug therapies: A preliminary biodistribution study of PRINT™ nanoparticles

Por Gratton, Stephanie E. A., Pohlhaus, Patrick D., Lee, Jin, Guo, Ji, Cho, Moo J., DeSimone, Joseph M.
Publicado em 2007

Planejamento, síntese e avaliação antiplasmodial de novas Pirrolo[3,4-d]-pirimidin-2,5-dionas /

Por Rogerio, Kamilla Rodrigues, Boechat, Núbia, Carvalho, Leonardo José de Moura, Aguiar, Lúcia Cruz de Sequeira, Universidade Federal do Rio de Janeiro.
Publicado em 2019

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy

Por Bot, Ilze, Ortiz Zacarías, Natalia V., de Witte, Wilhelmus E. A., de Vries, Henk, van Santbrink, Peter J., van der Velden, Daniël, Kröner, Mara J., van der Berg, Dirk-Jan, Stamos, Dean, de Lange, Elizabeth C. M., Kuiper, Johan, IJzerman, Adriaan P., Heitman, Laura H.
Publicado no Sci Rep (2017)